Skip to main content

Urinary Bladder

  • Chapter

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Barentsz JO, Jager GJ, Witjes JA, Ruijs JH: Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Radiol 6(2):129–133, 1996

    Article  PubMed  CAS  Google Scholar 

  • Brown JL, Russell PJ, Philips J, Wotherspoon J, Raghavan, D: Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61:369–376, 1990

    Article  PubMed  CAS  Google Scholar 

  • Cote RJ, Esrig D, Groshen S, et al: p53 and treatment of bladder cancer. Nature 385:123–124, 1997

    Article  PubMed  CAS  Google Scholar 

  • de Vere White RW, Olsson CA, Deitch AD: Flow cytometry: role in monitoring transitional cell carcinoma of bladder. Urology 28:15–20, 1986

    Article  Google Scholar 

  • Esrig D, Elmajian D, Groshen S, et al: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259–1264, 1994

    Article  PubMed  CAS  Google Scholar 

  • Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A: Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer 67:1525–1531, 1991

    Article  PubMed  CAS  Google Scholar 

  • Greenlee RT, Hill-Harmon MB, Taylor M, Thun M: Cancer Statistics, 2001. CA Cancer J Clin 51:15–36, 2001

    Article  PubMed  CAS  Google Scholar 

  • Herr HW: Staging invasive bladder tumors. J Surg Oncol 51:217–220, 1992

    Article  PubMed  CAS  Google Scholar 

  • Herr HW, Lamm DL, Denis L: Management of superficial bladder cancer. In Raghavan D, Scher HI, Leibel SA, Lange PH (Eds.): Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 273–280, 1997

    Google Scholar 

  • Jewett HJ, Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 55:366–372, 1946

    PubMed  CAS  Google Scholar 

  • Johansson SL, Anderstrom CR: Primary adenocarcinoma of the urinary bladder and urachus. In Raghavan D, Brecher MI, Johnson DH, Meropol NJ, Moots PJ, Thigpen JT (Eds.): Textbook of uncommon cancer. Chichester, UK, NY: Wiley-Liss, 29–43, 1999

    Google Scholar 

  • Koss LG: Tumors of the urinary bladder. In Atlas of tumor pathology, 2nd series, fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1975.

    Google Scholar 

  • Loehrer PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 10:1066–1073, 1992

    PubMed  Google Scholar 

  • Michaud DS, Spiegelman D, Clinton SK, et al: Fluid intake and the risk of bladder cancer in men. New Engl J Med 340:1390–1397, 1999

    Article  PubMed  CAS  Google Scholar 

  • Neal DE, Marsh C, Bennett MK, et al: Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1:366–368, 1985

    Article  PubMed  CAS  Google Scholar 

  • Pagano F, Bassi P, Ferrante GL, et al: Is stage pT4 (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urology 155:244–247, 1996

    Article  CAS  Google Scholar 

  • Pagano F, Guazzieri S, Artibani W, et al: Prognosis of bladder cancer. III. The value of radical cystectomy in the management of invasive bladder cancer. Eur Urol 15:166–170, 1988

    PubMed  CAS  Google Scholar 

  • Raghavan D, Shipley WU, Garnick MB, et al: Biology and management of bladder cancer. N Engl J Med 322:1129–1133, 1990

    Article  PubMed  CAS  Google Scholar 

  • Sarkis AS, Dalbagni G, Cordon-Cardo C, et al: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol 152:388–392, 1994

    PubMed  CAS  Google Scholar 

  • Saxman SB, Propert K, Einhorn LH, et al: Long-term follow-up of phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 15:2564–2569, 1997

    PubMed  CAS  Google Scholar 

  • Shipley WU, Prout GR Jr, Kaufman DS, Peronne TL: Invasive bladder carcinoma: the importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60:514, 1987

    Article  PubMed  CAS  Google Scholar 

  • Siemiatycki J, Dewar R, Nadon L, et al: Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 140:1061–1080, 1994

    PubMed  CAS  Google Scholar 

  • Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, et al: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784–788, 1994

    PubMed  CAS  Google Scholar 

  • Stein JP, Ginsberg DA, Grossfeld GD, et al: Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 90:1072–1079, 1998

    Article  PubMed  CAS  Google Scholar 

  • Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of high grade, invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001, 19(X):66

    Google Scholar 

  • Sternberg CN, Swanson DA: Non-transitional cell bladder cancer. In Raghavan D, Scher HI, Leibel SA, Lange PH (Eds.): Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 315–330, 1997

    Google Scholar 

  • Torti FM, Lum BL, Astron D, et al: Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol 5:125, 1987

    PubMed  CAS  Google Scholar 

  • Wishnow KI, Levinson AK, Johnson DE: Stage B (P2/3aN0) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology 39:12–16, 1992

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Consortia

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

American Joint Committee on Cancer. (2002). Urinary Bladder. In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3656-4_38

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-3-540-00595-7

  • Online ISBN: 978-1-4757-3656-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics